JPS6361951B2 - - Google Patents
Info
- Publication number
- JPS6361951B2 JPS6361951B2 JP54122216A JP12221679A JPS6361951B2 JP S6361951 B2 JPS6361951 B2 JP S6361951B2 JP 54122216 A JP54122216 A JP 54122216A JP 12221679 A JP12221679 A JP 12221679A JP S6361951 B2 JPS6361951 B2 JP S6361951B2
- Authority
- JP
- Japan
- Prior art keywords
- pho
- hydrogen
- compound
- hydroxyl group
- epi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 41
- 239000001257 hydrogen Substances 0.000 claims description 30
- 229910052739 hydrogen Inorganic materials 0.000 claims description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 19
- 125000001589 carboacyl group Chemical group 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 10
- 150000002431 hydrogen Chemical group 0.000 claims description 9
- 241000187747 Streptomyces Species 0.000 claims description 6
- 241000203590 Streptosporangium Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 201000006652 primary hypertrophic osteoarthropathy Diseases 0.000 description 56
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 23
- 229920002795 polyhydroxyoctanoate Polymers 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- -1 isobutyryl Chemical group 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000005273 aeration Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101100083253 Caenorhabditis elegans pho-1 gene Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 101100083259 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pho-4 gene Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical group 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000013076 target substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QWPXBEHQFHACTK-KZVYIGENSA-N (10e,12e)-86-chloro-12,14,4-trihydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-15,16-dihydro-14h-7-aza-1(6,4)-oxazina-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-6-one Chemical compound CN1C(=O)CC(O)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 QWPXBEHQFHACTK-KZVYIGENSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QWPXBEHQFHACTK-UHFFFAOYSA-N Maytansinol Natural products CN1C(=O)CC(O)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)C=CC=C(C)CC2=CC(OC)=C(Cl)C1=C2 QWPXBEHQFHACTK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000203587 Streptosporangium roseum Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 238000005377 adsorption chromatography Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 241000187681 Nocardia sp. Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000970232 Streptomyces flavochromogenes Species 0.000 description 1
- 241000970935 Streptomyces minutiscleroticus Species 0.000 description 1
- 241000933809 Streptomyces niger Species 0.000 description 1
- 241000970900 Streptomyces olivaceiscleroticus Species 0.000 description 1
- 241000187090 Streptomyces sclerotialus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- MQYZCKOGTWYJAZ-UHFFFAOYSA-N ansamitocin P1 Natural products CN1C(=O)CC(OC(C)=O)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)C=CC=C(C)CC2=CC(OC)=C(Cl)C1=C2 MQYZCKOGTWYJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NRTYQRNSFIFOAX-UHFFFAOYSA-N maytanbutacine Natural products CN1C(=O)CC(OC(=O)C(C)C)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)C=CC=C(C)C(OC(C)=O)C2=CC(OC)=C(Cl)C1=C2 NRTYQRNSFIFOAX-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、C−15003PHO類およびその製造法
に関する。
本発明者らは、あるメイタンシノイド化合物を
微生物により他の化合物へ変換する方法を検索し
たところ、ある微生物の培養物又はその処理物を
あるメイタンシノイド化合物に作用させると、該
メイタンシノイド化合物の15位に水酸基を導入し
得ることを知り、これに基づいてさらに研究した
結果、本発明を完成した。
すなわち本発明は、(1)一般式()
〔式中、R1およびR2は、一方が水酸基で他方
が水素を、R3は水素または炭素数5以下のアル
カノイルを表わす。ただし、R1が水酸基でかつ
R2が水素のときR3は水素または
The present invention relates to C-15003PHOs and a method for producing the same. The present inventors searched for a method of converting a certain maytansinoid compound into another compound using a microorganism, and found that when a culture of a certain microorganism or its processed material is applied to a certain maytansinoid compound, the maytansinoid The inventors discovered that it was possible to introduce a hydroxyl group into the 15th position of a compound, and as a result of further research based on this knowledge, the present invention was completed. That is, the present invention provides (1) general formula () [In the formula, one of R 1 and R 2 represents a hydroxyl group and the other represents hydrogen, and R 3 represents hydrogen or an alkanoyl having 5 or less carbon atoms. However, if R 1 is a hydroxyl group and
When R 2 is hydrogen, R 3 is hydrogen or
【式】以外の炭素数5以下のアルカ
ノイルを表わす。R1が水素でかつR2が水酸基の
ときR3は水素または炭素数5以下のアルカノイ
ルを表わす。〕で表わされるメイタンシノイド化
合物()および(2)一般式()
〔式中、R′3は水素または炭素数5以下のアル
カノイルを表わす。〕で表わされるメイタンシノ
イド化合物()に該メイタンシノイド化合物の
15位に水酸基を導入する能力を有するストレプト
ミセス属、チヤイニア属またはストレプトスポラ
ンギウム属に属する微生物の培養物または処理物
を接触させることを特徴とするメイタンシノイド
化合物()の製造法である。
上記一般式中、R3あるいはR′3で表わされる炭
素数5以下のアルカノイルとしては、たとえば、
ホルミル(−CHO)、アセチル(−COCH3),プ
ロピオニル(−COCH2CH2),ブチリル(−
COCH2CH2CH3)、イソブチリル
Represents an alkanoyl having 5 or less carbon atoms other than [Formula]. When R 1 is hydrogen and R 2 is a hydroxyl group, R 3 represents hydrogen or alkanoyl having 5 or less carbon atoms. ] Maytansinoid compounds () and (2) general formula () [In the formula, R'3 represents hydrogen or alkanoyl having 5 or less carbon atoms. ] of the maytansinoid compound ()
A method for producing a maytansinoid compound (), which is characterized by contacting a culture or treated product of a microorganism belonging to the genus Streptomyces, the genus Chiainia, or the genus Streptosporangium, which has the ability to introduce a hydroxyl group at the 15th position. . In the above general formula, the alkanoyl having 5 or less carbon atoms represented by R 3 or R′ 3 is, for example,
Formyl (-CHO), acetyl (-COCH 3 ), propionyl (-COCH 2 CH 2 ), butyryl (-
COCH 2 CH 2 CH 3 ), isobutyryl
【式】バレリル(−
COCH2CH2CH2CH3),イソバレリル
[Formula] Valeryl (-COCH 2 CH 2 CH 2 CH 3 ), Isovaleryl
【式】などが挙げられる。
本明細書においては「C−15003PHO」または
「PHO」とは上記一般式()においてR1が水酸
基ありかつR2が水素であるすべての化合物の総
称、二つまたはそれ以上の混合物またはそれぞれ
の単一化合物というものとする。また、一般式
()においてはR1が水酸基、R2が水素であり、
R3が水素の化合物を「C−15003PHO−O」また
は「PHO−O」と、R′3が−COCH3の化合物を
「C−15003PHO−1」または単に「PHO−1」
と、R3が−COCH2CH3の化合物を「C−
15003PHO−2」または「PHO−2」と、R3が
Examples include [Formula]. In this specification, "C-15003PHO" or "PHO" is a general term for all compounds in which R 1 is a hydroxyl group and R 2 is hydrogen in the above general formula (), a mixture of two or more, or a mixture of two or more, or a mixture of two or more, or a mixture of two or more of them. It is referred to as a single compound. In addition, in the general formula (), R 1 is a hydroxyl group, R 2 is hydrogen,
A compound where R 3 is hydrogen is called "C-15003PHO-O" or "PHO-O", and a compound where R' 3 is -COCH 3 is called "C-15003PHO-1" or simply "PHO-1".
, a compound in which R 3 is -COCH 2 CH 3 is called "C-
15003PHO-2” or “PHO-2” and R 3
【式】の化合物を「C−15003PHO
−3」または「PHO−3」と、R3が
The compound of [formula] is called "C-15003PHO-3" or "PHO-3", and R 3 is
【式】の化合物「C−
15003PHO−4」または「PHO−4」と、それ
ぞれ称するものとする。
また、「C−15003epi−PHO」とは上記一般式
()においてR1が水素でありかつR2が水酸基で
あるすべての化合物の総称、二つまたはそれ以上
の混合物またはそれぞれの単一化合物というもの
とする。また、一般式()においてR1が水素
でR2が水酸基であり、R3が水素の化合物を「C
−15003−epi−PHO−0」または「epi−PHO−
0」と、R3が−COCH3の化合物を「C−
15003epi−PHO−1」または「epi−PHO−1」
と、R3が−COCH2CH3の化合物を「C−
15003epi−PHO−2」または「epi−PHO−2」
と、R3がThe compound of the formula will be referred to as "C-15003PHO-4" or "PHO-4", respectively. In addition, "C-15003epi-PHO" is a general term for all compounds in which R 1 is hydrogen and R 2 is a hydroxyl group in the above general formula (), a mixture of two or more, or a single compound of each. shall be taken as a thing. In addition, in the general formula (), a compound in which R 1 is hydrogen, R 2 is a hydroxyl group, and R 3 is hydrogen is referred to as "C
−15003−epi−PHO−0” or “epi−PHO−
0'' and a compound where R 3 is -COCH 3 is called ``C-
15003epi-PHO-1” or “epi-PHO-1”
, a compound in which R 3 is -COCH 2 CH 3 is called "C-
15003epi-PHO-2” or “epi-PHO-2”
and R 3 is
【式】の化合物を「C−
15003epi−PHO−3」または「epi−PHO−3」
と、R3がThe compound of [formula] is "C-15003epi-PHO-3" or "epi-PHO-3"
and R 3 is
【式】の化合物を「C
−15003epi−PHO−4」または「epi−PHO−
4」と、それぞれ称するものとする。
また一般式()においてR′3が水素の化合物
メイタンシノール「P−0」と、R′3が−COCH3
の化合物メイタナシンを「P−1」と、R′3が−
COCH2CH3の化合物メイタンシノールプロピオ
ネートを「P−2」と、R′3が
The compound of [formula] is "C-15003epi-PHO-4" or "epi-PHO-
4" respectively. Also, in the general formula (), the compound maytansinol "P-0" where R' 3 is hydrogen and the compound maytansinol "P-0" where R' 3 is -COCH 3
The compound maytanacin is referred to as “P-1”, and R′ 3 is −
The compound maytansinol propionate of COCH 2 CH 3 is called “P-2” and R′ 3 is
【式】の化合物を「C−15003P−
3」または「P−3」と、R′3が−
COCH2CH2CH3の化合物を「C−15003P−3′」
または「P−3′」と、R′3が
The compound of [formula] is "C-15003P- 3" or "P-3" and R' 3 is -
The compound of COCH 2 CH 2 CH 3 is called “C-15003P-3′”
or “P-3′” and R′ 3 is
【式】の化合物を「C−15003P
−4」または「P−4」と、それぞれ称するもの
とする。
P−0,P−1,P−2,P−3,P−3′,P
−4は、たとえばノカルデイア(Nocardia)sp.
No.C−15003株〔工業技術院微生物工業技術研究
所にFERM−PNo.3992として、財団法人発酵研
究所にIFO−13726として、ジ・アメリカン・タ
イプ・カルチヤー・コレクシヨン(The
American Type Culture Collection)にATCC
−31281として、それぞれ寄託されている。〕を培
地に培養し、培養物から採取精製することにより
得られる〔特開昭53−1211998号公報、特開昭53
−130693号公報、ネイチヤー(Nature)
vol.270,p.721(1977),テトラヘドロン
(Tetrahedron)第35巻,1079頁(1979年)参
照〕。
また、P−0は、P−3,P−3′および/また
はP−4を脱アシル化反応に付すことによつても
得られる〔特開昭53−130693号公報,ネイチヤー
vo1.270,P.721(1977),テトラヘドロン第35巻,
1079頁(1979年)参照〕。
さらに、R′3が水素以外の置換基である一般式
()の化合物は、P−0に、相当するカルボン
酸から誘導される一般式
〔式中、R4は炭素数5以下のアルカノイルを
表わす。〕で表わされる酸無水物あるいは一般式
R4X ()
〔式中、R4は前記と同意義。Xはハロゲンを
表わす。〕で表わされる酸ハライドを反応させる
ことによつて製造することができる。
R4で表わされる炭素数5以下のアルカノイル
としては、前記R′3と同様のものが挙げられる。
上記一般式()においてXで表わされるハロ
ゲンとしては、たとえば塩素、臭素、ヨウ素が挙
げられる。上記の反応は、塩基の存在下に行なう
と好ましい場合がある。該塩基としてはたとえ
ば、トリエチルアミン、トリブチルアミン、ピリ
ジン、4−ジメチルアミノピリジン、α−,β
−,γ−ピコリン,2,6−ルチジン,ジメチル
アニリン,ジエチルアニリン,N−メチルモルホ
リンなどの第3級アミンなどが挙げられる。ま
た、上記の反応においては、適当な溶媒を使用し
てもよい、該溶媒としては、たとえば酢酸エチル
などのエステル,ジエチルエーテル,ジオキサ
ン,テトラヒドロフランなどのエーテル,メチレ
ンクロリド,クロロホルムなどのハロゲン化炭化
水素、アセトニトリルなどのニトリル、ベンゼン
などの芳香族炭化水素、ニトロメタン、ジメチル
ホルムアミド,ジメチルスルホキシド,スルホラ
ンなどが挙げられ、これらの混合物もよい。ま
た、前記の塩基を溶媒として用いてもよく、該塩
基と上記の溶媒との混合物を溶媒として用いても
よい。上記の反応を行なう際の温度は、特に限定
されないが、−20℃乃至40℃が適当である。この
ようにして得られたR′3が水素以上の置換基であ
る一般式()の化合物は、通常用いられる分離
精製手段、たとえば溶媒による抽出、クロマトグ
ラフイー、再結晶などを適宜利用することにより
精製することがきる。
本発明方法で用いられる微生物は、ストレプト
ミセス(Streptomyces)属、チヤイニア
(Chainia)属またはストレプトスポランギウム
(Streptosporangium)属に属し、かつメイタン
シノイド化合物()の15位に水酸基を導入する
能力を有する微生物およびその変異株であればい
ずれもよい。本発明方法で用いられることの出来
る微生物としては、たとえばストレプトミセス・
スクレロチアルス(Streptomyces sclerotialus)
IFO 12246,ストレプトミセス・カスタネウス
(Streptomyces castneus)IFO13670,ストレプ
トミセス・フラボクロモゲネス(Strepto−
myces flavochromogenes)IFO13443,ストレ
プトミセス・オリバセイスクレロチカス
(Streptomyces olivaceiscle−roticus)
IFO13484,ストレプトミセス・フラビスクレロ
チカス(Streptomyces flaviscleroticus)
IFO13357,チヤイニア・ニグラ(Chainia
nigra)IFO13362およびストレプトスポランポラ
ンギウム・ロゼウム(Streptosporangium
roseum)IFO3776などが挙げられる。上記の
IFO112246,IFO13670,IFO13443,IFO13484,
IFO13357,IFO13362およびIFO3776は、財団法
人発酵研究所のリスト・オブ・カルチヤーズ1978
年、第6版(Institute for Fermentation,
Osaka List of Cultures1978sixth edition)に
記載されており、いずれも該発酵研究所から入手
することが出来る。
一般に、ストレプトミセス属菌,チヤイニア属
菌,ストレプトスポランポラギウム属菌は、その
性状が変化しやすく、たとえばX線照射,紫外線
照射,放射線照射,人工変異剤(例、ニトロソグ
アニジン,エチレンイミンなど)を用いる人工変
異手段など容易に変異しうる。このような変異株
であつても、メイタンシノイド化合物()の15
位に水酸基を導入する能力を有するものは、すべ
て本発明方法に使用し得る。
本発明の方法における上記の微生物の培養に用
いられる培地は該菌株が利用し得る栄養源を含む
ものなら、液状でも固状でもよいが、大量を処理
するときには液体培地を用いるのがより適当であ
る。培地には上記の微生物が同化し得る炭素源,
消化し得る窒素源,無機物質,微量栄養素等が適
宜配合される。炭素源としては、たとえばブドウ
糖,乳糖,シヨ糖,麦芽糖,デキストリン,でん
粉,グリセロール,マンニトール,ソルビトール
等,油脂類(例、大豆油,ラード油,チキン油
等)その他が、窒素源としては、たとえば肉エキ
ス,酵母エキス,乾燥酵母,大豆粉,コーン・ス
チープ,リカー,ペプトン,棉実粉,癈糖密,尿
素,アンモニウム塩類(例、硫酸アンモニウム,
塩化アンモニウム,硝酸アンモニウム,酢酸アン
モニウム等)その他が用いられる。さらにナトリ
ウム,カリウム,カルシウム,マグネシウムなど
を含む塩類,鉄,マンガン,亜鉛,コバルト,ニ
ツケルなの金属塩類,リン酸,ホウ酸などの塩類
や酢酸,プロピオン酸などの有機酸の塩類が適宜
用いられる。その他、アミノ酸(例、グルタミン
酸,アスパラギン酸,アラニン,グリシン,リジ
ン,メチオニン,プロリン等),ペプチド(例、
ジペプチド,トリペプチド等),ビタミン類(例、
B1,B2,ニコチン酸,B12,C,E等),核酸類
(例、プリン,ピリミジンおよびその誘導体等)
等を含有させてもよい。もちろん培地のPHを調節
する目的で無機または有機の酸,アルカリ類,緩
衝剤等を加え、あるいは消泡の目的で油脂類,表
面活性剤等の適量を添加してもよい。
培養の手段は静置培養でも、振盪培養あるいは
通気撹拌培養法等の手段を用いてもよい。大量の
処理には、いわゆる深部通気撹拌培養によるのが
望ましいことはいうまでもない。培養の条件は培
地の状態,組成,菌株の種類,培養の手段等によ
つて一定しないのは当然であるが、それらは通常
20℃〜45℃の温度で初発PHを中性附近に選択する
のがよい。とりわけ、培養中期の温度は24℃〜37
℃、また初発PHは6.5〜8.5の条件が望ましい。培
養時間は6〜100時間程度で良いが、とくに16〜
48時間で良好である。
本発明で用いられる「培養物」とは、上記の培
養で得られるものをいう。
本発明で用いられる「処理物」とは、上記で得
られる培養物を物理化学的処理たとえばろ過,遠
心分離,超音波処理,フレンチプレス処理,アル
ミナ磨砕,溶菌酵素処理,界面活性剤または有機
溶媒処理などで得た菌体あるいは水酸化酵素を含
む菌体破砕物という。また公知の方法で精製して
得られる水酸化酵素または公知の方法で固定化し
た菌体または水酸化酵素も用いることも出来る。
本発明方法は、原料化合物()と上記の微生
物の培養物またはその処理物とを接触させて行な
われる。反応液中の原料化合物の濃度は1〜
500μg/mlが適当である。反応温度は20〜50℃,
PHは5〜10が適当であるが、特に温度24〜40℃,
PH6〜9が良好である。反応時間は1〜200時間、
さらに好ましくは24〜72時間が適当である。また
反応は静止下でも振とう、通気またはかくはんの
条件下でもよいが、振とう、通気またはかくはん
する方が良好である。
このようにして得られた物質の検出は薄層クロ
マトグラフイー法(以下、TLCと略す)により
測定できる。反応液を酢酸エチルで抽出し、1/10
0容量まで濃縮した液をシリカゲルガラスプレー
ト(西独メルク社,キーゼルゲル60F254,0.25
mm,20×20cm)を担体としたTLCに付し(溶
媒:クロロホルム:メタノール=9:1),紫外
線2537Åを照射して検出される吸収像で測定す
る。
反応液中から目的物を採取するには本物質群が
中性脂溶性であるため、通常微生物代謝物を採取
するために用いられる分離精製の方法を適宜利用
することができる。たとえば不純物との溶解度の
差を利用する手段,活性炭,マクロポーラス非イ
オン系樹脂,シリカゲル、アルミナ等各種の吸着
剤の吸着親和力の差を利用する手段,イオン交換
樹脂による不純物の除去手段のいずれもがそれぞ
れ単独で、また組合せて、あるいは反覆して利用
される。溶解度の差を利用する場合、液からの
抽出に適当な溶媒としては水と混じらない有機溶
媒、たとえば酢酸エチル,酢酸アルミなどの脂肪
酸エステル,ブタノールなどのアルコール類,ク
ロロホルムなどのハロゲン化炭化水素,メチルイ
ソブチルケトンなどのケトン類が用いられる、抽
出は中性附近で行なわれ、好ましくはPH7に調整
された培養液から酢酸エチルを用いて行なわれ
る。抽出液を水洗後減圧下に濃縮し、石油エーテ
ル,ヘキサンのような非極性溶媒を加えて有効成
分を含む粗物質(i)を採取する。この中にはTLC
上で目的物質PHOおよび目的物質epi−PHO以
外の多数のスポツトが認められるため、段階的に
つぎの精製工程が利用される。すなわち、通常用
いられる精製法として種々の吸着クロマトグラフ
イーが有効であり、吸着剤としては、一般に使用
される担体、たとえばシリカゲル,アルミナ,マ
クロポーラス非イオン系吸着樹脂等が使用できる
が、粗物質(i)よりの精製にはシリカゲルが最も有
効に利用され、非極性溶媒、たとえば石油エーテ
ル,ヘキサンから展開をはじめ、酢酸エチル,ア
セトン,エタノール,メタノールのような極性溶
媒を添加することにより目的物質PHOおよびepi
−PHOの溶出を行う。その1例を示すとシリカ
ゲル(西独メルク社,0.05〜0.2mm)を担体とし、
ヘキサン,酢酸エチルの混合比を順次増加しなが
らカラムクロマトグラフイーを行い、溶出液を
TLCでしらべてPHOおよびepi−PHOを含有す
るフラクシヨンを集め、減圧濃縮して石油エーテ
ルまたはヘキサンを加え粗物質(ii)を得る。この中
にはまだ、他の不純物を多く含む場合は、つぎの
精製を行う。たとえば溶媒系をかえた第2のシリ
カゲルカラムにより精製する。この場合の展開溶
媒には、ジクロルメタン,クロロホルムのような
含ハロゲン炭化水素類から展開をはじめ、エタノ
ール,メタノールのようなアルコール類、アセト
ン,メチルエチルケトンのようなケトン類等極性
溶媒を添加することにより目的物質PHO,epi−
PHOを分離採取する。第1,第2のシリカゲル
カラムの溶媒系の組み合わせは、前後を逆にして
もあるいは単独でも可能であつて、その他通常用
いられる有機溶媒が適宜組み合わされる。
得られた粗物質(iii)中にPHOの他にepi−PHO
を含む場合は、さらにつぎの精製工程が利用され
る。すなわち上記の種々の吸着クロマトグラフイ
ーおよび分配クロマトグラフイーが有効である
が、粗物質(iii)よりの精製には逆相用分配用ゲルを
利用して分離するのが有利である。溶出溶媒とし
て水と混合するアルコール,ケトン類が用いられ
る。その1例を示すと逆相用ゲルC18(米国,ウオ
ーターズ社,PrepPAK−500/C18)などで高速
液体クロマトグラフPrepLC/system500(米国,
ウオーターズ社)を用いて調製的分取を行う。溶
媒として含水メタノールを用いるとepi−PHO,
PHOの順序で溶出されるので、逆相用TLC(西
独,メルク社)により検出後epi−PHO,PHO
の区分を減圧濃縮する。得られた濃縮液をそれぞ
れ酢酸エチルで抽出し、減圧濃縮し少量のメタノ
ールを加えて放置するとそれらの無色結晶が得ら
れる。
後述の実施例5で得られたPHO−0,実施例
7で得られたPHO−1,実施例9で得られた
PHO−2,実施例3で得られたPHO−3,実施
例11で得られたPHO−4,実施例5で得られた
epi−PHO−0,実施例7で得られたepi−PHO
−1,実施例9で得られたepi−PHO−2,実施
例3で得られたepi−PHO−3,実施例11で得ら
れたepi−PHO−4の物理化学的性状を第1表お
よび第2表に示す。The compound of the formula will be referred to as "C-15003P-4" or "P-4", respectively. P-0, P-1, P-2, P-3, P-3', P
-4, for example, Nocardia sp.
No. C-15003 strain [FERM-P No. 3992 to the Institute of Microbial Technology, Agency of Industrial Science and Technology, IFO-13726 to the Fermentation Research Institute, The American Type Culture Collection (The
American Type Culture Collection) ATCC
-31281, respectively. ] can be obtained by culturing it in a medium and collecting and purifying it from the culture [JP-A-53-1211998;
−130693 Publication, Nature
vol. 270, p. 721 (1977), Tetrahedron vol. 35, p. 1079 (1979)]. P-0 can also be obtained by subjecting P-3, P-3' and/or P-4 to a deacylation reaction [JP-A-53-130693, Nature
vo1.270, P.721 (1977), Tetrahedron Volume 35,
See page 1079 (1979)]. Furthermore, compounds of the general formula () in which R′ 3 is a substituent other than hydrogen, P-0 has a general formula derived from the corresponding carboxylic acid. [In the formula, R 4 represents an alkanoyl having 5 or less carbon atoms. ] or the general formula R 4 X ( ) [wherein R 4 has the same meaning as above. X represents halogen. ] It can be produced by reacting an acid halide represented by: Examples of the alkanoyl having 5 or less carbon atoms represented by R 4 include the same as R' 3 above. Examples of the halogen represented by X in the above general formula () include chlorine, bromine, and iodine. It may be preferable to carry out the above reaction in the presence of a base. Examples of the base include triethylamine, tributylamine, pyridine, 4-dimethylaminopyridine, α-, β
Examples include tertiary amines such as -, γ-picoline, 2,6-lutidine, dimethylaniline, diethylaniline, and N-methylmorpholine. In addition, in the above reaction, a suitable solvent may be used, such as esters such as ethyl acetate, ethers such as diethyl ether, dioxane, and tetrahydrofuran, and halogenated hydrocarbons such as methylene chloride and chloroform. , nitriles such as acetonitrile, aromatic hydrocarbons such as benzene, nitromethane, dimethylformamide, dimethyl sulfoxide, sulfolane, etc., and mixtures thereof may also be used. Further, the above base may be used as a solvent, or a mixture of the base and the above solvent may be used as a solvent. The temperature at which the above reaction is carried out is not particularly limited, but -20°C to 40°C is suitable. The thus obtained compound of general formula () in which R′ 3 is a substituent of hydrogen or more can be obtained by appropriately using commonly used separation and purification means such as extraction with a solvent, chromatography, recrystallization, etc. It can be purified by The microorganism used in the method of the present invention belongs to the genus Streptomyces, Chainia, or Streptosporangium, and has the ability to introduce a hydroxyl group into the 15-position of the maytansinoid compound (). Any microorganism or mutant strain thereof may be used. Examples of microorganisms that can be used in the method of the present invention include Streptomyces
Streptomyces sclerotialus
IFO 12246, Streptomyces castneus IFO13670, Streptomyces flavochromogenes
myces flavochromogenes) IFO13443, Streptomyces olivaceiscle−roticus
IFO13484, Streptomyces flaviscleroticus
IFO13357, Chainia nigra
nigra) IFO13362 and Streptosporangium roseum (Streptosporangium roseum)
roseum) IFO3776. above
IFO112246, IFO13670, IFO13443, IFO13484,
IFO13357, IFO13362 and IFO3776 are listed in the List of Cultures 1978 by the Fermentation Research Institute.
, 6th edition (Institute for Fermentation,
Osaka List of Cultures 1978 sixth edition), and both can be obtained from the Fermentation Research Institute. In general, Streptomyces, Chiainia, and Streptosporanporagium are susceptible to changes in their properties, such as X-ray irradiation, ultraviolet irradiation, radiation irradiation, and artificial mutagens (e.g., nitrosoguanidine, ethyleneimine, etc.). ) can be easily mutated using artificial mutation means. Even in such mutant strains, maytansinoid compounds () 15
Anything that has the ability to introduce a hydroxyl group into the position can be used in the method of the present invention. The medium used for culturing the above-mentioned microorganisms in the method of the present invention may be either liquid or solid as long as it contains a nutrient source that can be used by the strain, but it is more appropriate to use a liquid medium when processing a large amount. be. The culture medium contains carbon sources that can be assimilated by the above microorganisms,
Digestible nitrogen sources, inorganic substances, micronutrients, etc. are appropriately blended. Carbon sources include, for example, glucose, lactose, sucrose, maltose, dextrin, starch, glycerol, mannitol, sorbitol, etc., oils and fats (eg, soybean oil, lard oil, chicken oil, etc.), and nitrogen sources include, for example. Meat extract, yeast extract, dried yeast, soy flour, corn steep, liquor, peptone, cotton powder, molasses, urea, ammonium salts (e.g. ammonium sulfate,
Ammonium chloride, ammonium nitrate, ammonium acetate, etc.) and others are used. Further, salts containing sodium, potassium, calcium, magnesium, etc., metal salts of iron, manganese, zinc, cobalt, nickel, etc., salts of phosphoric acid, boric acid, etc., and salts of organic acids such as acetic acid, propionic acid, etc. are used as appropriate. In addition, amino acids (e.g., glutamic acid, aspartic acid, alanine, glycine, lysine, methionine, proline, etc.), peptides (e.g.,
dipeptides, tripeptides, etc.), vitamins (e.g.
B 1 , B 2 , nicotinic acid, B 12 , C, E, etc.), nucleic acids (e.g., purines, pyrimidines and their derivatives, etc.)
etc. may be included. Of course, inorganic or organic acids, alkalis, buffers, etc. may be added for the purpose of adjusting the pH of the medium, or appropriate amounts of oils and fats, surfactants, etc. may be added for the purpose of defoaming. The culturing method may be static culture, shaking culture, or aeration/agitation culture. It goes without saying that for large-scale treatment, it is desirable to use so-called deep aeration agitation culture. It goes without saying that culture conditions vary depending on the condition and composition of the medium, the type of strain, the culture method, etc., but these are usually
It is best to select the initial pH to be around neutral at a temperature of 20°C to 45°C. In particular, the temperature during the middle stage of cultivation is between 24°C and 37°C.
℃, and the initial pH is preferably 6.5 to 8.5. Cultivation time may be about 6 to 100 hours, but especially 16 to 100 hours.
Good in 48 hours. The "culture" used in the present invention refers to what is obtained by the above-mentioned culture. The "processed product" used in the present invention refers to the culture obtained as described above subjected to physicochemical treatment such as filtration, centrifugation, ultrasonication, French press treatment, alumina grinding, lytic enzyme treatment, surfactant or organic It is called bacterial cells obtained by solvent treatment or crushed bacterial cells containing hydroxylase. Furthermore, hydroxylase obtained by purification by a known method, or bacterial cells or hydroxylase immobilized by a known method can also be used. The method of the present invention is carried out by bringing the raw material compound () into contact with the culture of the above-mentioned microorganism or its treated product. The concentration of the raw material compound in the reaction solution is 1~
500 μg/ml is appropriate. Reaction temperature is 20~50℃,
A pH of 5 to 10 is appropriate, especially at a temperature of 24 to 40℃,
PH6-9 is good. Reaction time is 1-200 hours,
More preferably, 24 to 72 hours is appropriate. Further, the reaction may be carried out under static conditions or under conditions of shaking, aeration or stirring, but it is better to carry out the reaction under shaking, aeration or stirring. The substance thus obtained can be detected by thin layer chromatography (hereinafter abbreviated as TLC). Extract the reaction solution with ethyl acetate and dilute to 1/10
The liquid concentrated to 0 volume was poured onto a silica gel glass plate (West German Merck & Co., Kieselgel 60F 254 , 0.25
The sample is subjected to TLC using a carrier (solvent: chloroform: methanol = 9:1) and measured by the absorption image detected by irradiation with ultraviolet rays of 2537 Å. To collect the target product from the reaction solution, separation and purification methods normally used for collecting microbial metabolites can be used as appropriate, since this group of substances is neutral fat-soluble. For example, there are methods that utilize differences in solubility with impurities, methods that utilize differences in adsorption affinity of various adsorbents such as activated carbon, macroporous nonionic resins, silica gel, and alumina, and methods that remove impurities using ion exchange resins. may be used alone, in combination, or repeatedly. When utilizing the difference in solubility, suitable solvents for extraction from liquids include organic solvents that are immiscible with water, such as fatty acid esters such as ethyl acetate and aluminum acetate, alcohols such as butanol, halogenated hydrocarbons such as chloroform, etc. Ketones such as methyl isobutyl ketone are used. Extraction is performed near neutrality, preferably using ethyl acetate from a culture solution adjusted to pH 7. After washing the extract with water, it is concentrated under reduced pressure, and a non-polar solvent such as petroleum ether or hexane is added to collect the crude substance (i) containing the active ingredient. Some of this includes TLC
Since many spots other than the target substance PHO and target substance epi-PHO are observed above, the following purification steps are used in stages. In other words, various types of adsorption chromatography are effective as commonly used purification methods, and commonly used carriers such as silica gel, alumina, macroporous nonionic adsorption resins, etc. can be used as adsorbents; Silica gel is most effectively used for the purification of (i), and the target substance can be obtained by developing from non-polar solvents such as petroleum ether and hexane, and by adding polar solvents such as ethyl acetate, acetone, ethanol, and methanol. PHO and epi
- Perform elution of PHO. One example is using silica gel (West German Merck & Co., Ltd., 0.05-0.2 mm) as a carrier,
Perform column chromatography while gradually increasing the mixing ratio of hexane and ethyl acetate, and collect the eluate.
The fractions containing PHO and epi-PHO are collected by TLC analysis, concentrated under reduced pressure, and petroleum ether or hexane is added to obtain crude substance (ii). If this still contains many other impurities, the following purification is performed. For example, purification is performed using a second silica gel column using a different solvent system. In this case, the developing solvent may be a halogen-containing hydrocarbon such as dichloromethane or chloroform, or a polar solvent such as alcohols such as ethanol or methanol, or ketones such as acetone or methyl ethyl ketone. substance PHO, epi−
Separate and collect PHO. The combination of solvent systems for the first and second silica gel columns can be reversed or used alone, and other commonly used organic solvents may be appropriately combined. In addition to PHO, epi-PHO was present in the obtained crude substance (iii).
If it contains, the following purification step is further used. That is, although the above-mentioned various adsorption chromatography and partition chromatography are effective, it is advantageous to perform separation using a reversed-phase partition gel for purification of the crude substance (iii). Alcohols and ketones that mix with water are used as elution solvents. One example is a high-performance liquid chromatograph PrepLC/ system500 (U.S., Waters Inc., PrepPAK-500/C 18 ), etc.
Preparative fractionation is carried out using the Waters Co., Ltd.). When aqueous methanol is used as a solvent, epi-PHO,
Since it is eluted in the order of PHO, after detection by reverse phase TLC (Merck & Co., West Germany), epi-PHO, PHO
Concentrate the fraction under reduced pressure. The resulting concentrates are each extracted with ethyl acetate, concentrated under reduced pressure, and a small amount of methanol is added and allowed to stand, yielding colorless crystals. PHO-0 obtained in Example 5, PHO-1 obtained in Example 7, and PHO-1 obtained in Example 9, which will be described later.
PHO-2, PHO-3 obtained in Example 3, PHO-4 obtained in Example 11, PHO-4 obtained in Example 5
epi-PHO-0, epi-PHO obtained in Example 7
Table 1 shows the physicochemical properties of epi-PHO-2 obtained in Example 9, epi-PHO-3 obtained in Example 3, and epi-PHO-4 obtained in Example 11. and shown in Table 2.
【表】【table】
【表】【table】
【表】【table】
【表】
上述した物理化学的性状を既知メイタンシノイ
ド化合物と比較した結果、PHO−3は、ザ・ジ
ヤーナル・オブ・オーガニツク・ケミストリー
(The Journal of Organic Chemistry)第42巻,
2349頁(1977年)に記載されているデアセチルメ
イタンブタシン(de−acetylmaytanbutacine)
のそれらと良く一致した。また通常の方法により
PHO−3をアセチル化すると上記文献のメイタ
ンブタシン(maytanbutacine)の物理化学的性
状と良く一致した。しかし他のPHOおよびepi−
PHOと一致する化合物は認められなかつた。そ
こでまずepi−PHO−3をPHO−3と比較する。
マススペクトルでは同一のフラグメントが認めら
れるためepi−PHO−3はPHO−3と同様にP
−3に水酸基が導入された化合物であることが容
易に推定される。さらに核磁気共鳴スペクトルを
比較すると15位の水素がPHO−3ではδ5.37にシ
ングレツトで認められるが、epi−PHO−3では
δ5.11にシングレツトで認められることから、こ
の化合物はPHO−3の15位の立体異性体である
ことが容易に推定され、epi−PHO−3は新規化
合物であることがわかる。さらにX線解析の結果
epi−PHO−3のC15の絶対配位はSコンフイギ
ユレーシヨンであることがわかつた。他のPHO
ならびにepi−PHOをそれぞれPHO−3ならび
にepi−PHO−3と比較したところ、これらの構
造式は第1図および第2図に示されるものである
ことが分かる。[Table] As a result of comparing the above-mentioned physicochemical properties with known maytansinoid compounds, PHO-3 was found to be found in The Journal of Organic Chemistry, Vol. 42,
De-acetylmaytanbutacine described on page 2349 (1977)
It was in good agreement with those of Also, by the usual method
When PHO-3 was acetylated, the physicochemical properties matched well with the physicochemical properties of maytanbutacine described in the above literature. But other PHO and epi−
No compounds matching PHO were observed. First, let's compare epi-PHO-3 with PHO-3.
Since the same fragment is observed in the mass spectrum, epi-PHO-3 is PHO-3 as well as PHO-3.
It is easily presumed that this is a compound in which a hydroxyl group has been introduced into -3. Furthermore, when comparing the nuclear magnetic resonance spectra, hydrogen at position 15 is observed as a singlet at δ5.37 in PHO-3, but it is observed as a singlet at δ5.11 in epi-PHO-3. It is easily estimated that it is a stereoisomer at position 15 of , and epi-PHO-3 is found to be a new compound. Furthermore, the results of X-ray analysis
The absolute configuration of C15 in epi-PHO-3 was found to be the S configuration. Other PHOs
and epi-PHO are compared with PHO-3 and epi-PHO-3, respectively, and it is found that their structural formulas are shown in FIGS. 1 and 2.
【表】
\
CH3
【table】 \
CH3
参考例 4
実施例3で得られたepi−PHO−3(33mg)を
ピリジン1mlに溶解し、さらに無水酢酸4滴加え
一晩室温に放置する。以下参考例3と同様に処理
すると15−アセチルepi−PHO−3の結晶が得ら
れた(23mg)。
マススペクトル
m/e 692(M+)
m/e 631,571,556,536,483,468,
448
Rf=0.39
〔展開溶媒:水飽和酢酸エチル;プレート:シリ
カゲルガラスプレート(メルク社製)〕。
Reference Example 4 Epi-PHO-3 (33 mg) obtained in Example 3 was dissolved in 1 ml of pyridine, 4 drops of acetic anhydride was added, and the mixture was left at room temperature overnight. Thereafter, the same treatment as in Reference Example 3 was performed to obtain crystals of 15-acetyl epi-PHO-3 (23 mg). Mass spectrum m/e 692 (M + ) m/e 631, 571, 556, 536, 483, 468,
448 Rf=0.39 [Developing solvent: water-saturated ethyl acetate; plate: silica gel glass plate (manufactured by Merck & Co.)].
Claims (1)
が水素を、R3は水素または炭素数5以下のアル
カノイルを表わす。ただし、R1が水酸基でかつ
R2が水素のときR3は水素または
【式】以外の炭素数5以下のアルカ ノイルを表わす。R1が水素でかつR2が水酸基の
ときR3は水素または炭素数5以下のアルカノイ
ルを表わす。]で表わされるメイタンシノイド化
合物。 2 一般式 [式中、R′3は水素または炭素数5以下のアル
カノイルを表わす。]で表わされるメイタンシノ
イド化合物に該メイタンシノイド化合物の15位に
水酸基を導入する能力を有するストレプトミセス
属、チヤイニア属またはストレプトスポランギウ
ム属に属する微生物の培養物またはその処理物を
接触させることを特徴とする一般式 [式中、R1およびR2は、一方が水酸基で他方
が水素を、R3は水素または炭素数5以下のアル
カノイルを表わす。ただし、R1が水酸基でかつ
R2が水素のときR3は水素または
【式】以外の炭素数5以下のアルカ ノイルを表わす。R1が水素でかつR2が水酸基の
ときR3は水素または炭素数5以下のアルカノイ
ルを表わす。]で表わされるメイタンシノイド化
合物の製造法。[Claims] 1. General formula [In the formula, one of R 1 and R 2 represents a hydroxyl group and the other represents hydrogen, and R 3 represents hydrogen or an alkanoyl having 5 or less carbon atoms. However, if R 1 is a hydroxyl group and
When R 2 is hydrogen, R 3 represents hydrogen or an alkanoyl other than [Formula] having 5 or less carbon atoms. When R 1 is hydrogen and R 2 is a hydroxyl group, R 3 represents hydrogen or alkanoyl having 5 or less carbon atoms. ] maytansinoid compound. 2 General formula [In the formula, R'3 represents hydrogen or alkanoyl having 5 or less carbon atoms. ] maytansinoid compound is contacted with a culture of a microorganism belonging to the genus Streptomyces, genus Chiainia, or genus Streptosporangium, or a treated product thereof, which has the ability to introduce a hydroxyl group into the 15th position of the maytansinoid compound. A general formula characterized by [In the formula, one of R 1 and R 2 represents a hydroxyl group and the other represents hydrogen, and R 3 represents hydrogen or an alkanoyl having 5 or less carbon atoms. However, if R 1 is a hydroxyl group and
When R 2 is hydrogen, R 3 represents hydrogen or an alkanoyl other than [Formula] having 5 or less carbon atoms. When R 1 is hydrogen and R 2 is a hydroxyl group, R 3 represents hydrogen or alkanoyl having 5 or less carbon atoms. ] A method for producing a maytansinoid compound represented by
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12221679A JPS5645484A (en) | 1979-09-21 | 1979-09-21 | C-15003pho and its preparation |
| EP80105163A EP0028683A1 (en) | 1979-09-21 | 1980-08-29 | Antibiotic C-15003 PHO and production thereof |
| US06/188,238 US4364866A (en) | 1979-09-21 | 1980-09-17 | Maytansinoids |
| CA000360469A CA1146887A (en) | 1979-09-21 | 1980-09-18 | Antibiotic c-15003 pho and production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12221679A JPS5645484A (en) | 1979-09-21 | 1979-09-21 | C-15003pho and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5645484A JPS5645484A (en) | 1981-04-25 |
| JPS6361951B2 true JPS6361951B2 (en) | 1988-11-30 |
Family
ID=14830421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12221679A Granted JPS5645484A (en) | 1979-09-21 | 1979-09-21 | C-15003pho and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5645484A (en) |
-
1979
- 1979-09-21 JP JP12221679A patent/JPS5645484A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5645484A (en) | 1981-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0025898B1 (en) | Antibiotic c-15003 pnd-0 and production of antibiotic c-15003 pnd | |
| CA1155073A (en) | Antibiotic c-15003 phm and production thereof | |
| US4151042A (en) | Method for producing maytansinol and its derivatives | |
| CA1131144A (en) | Antibiotic c-15003 pnd | |
| EP0028683A1 (en) | Antibiotic C-15003 PHO and production thereof | |
| US5227295A (en) | Process for isolating A83543 and its components | |
| JPH0315633B2 (en) | ||
| US3189528A (en) | Resolution of racemic delta4-3-keto-13beta-alkyl steroids by using corynebacterium siplex | |
| JPS6316120B2 (en) | ||
| Marshall et al. | Reductive microbial conversion of anthracycline antibiotics | |
| JPS6361951B2 (en) | ||
| PL108863B1 (en) | Method of producing maytansinol and derivatives thereof | |
| Fantin et al. | Regioselective microbial oxidation of bile acids | |
| EP0046769B1 (en) | Fermentation of bile | |
| JPS625990A (en) | Antibiotic substance and production thereof | |
| US4587237A (en) | Mycotrienin-related compounds | |
| US2962512A (en) | Oxidation of steroids and products thereof | |
| JPH10508476A (en) | Microbial conversion method to obtain antibiotic GE2270 factor D (2) | |
| JPH07233184A (en) | Novel antitumor antibiotic | |
| JPS6034556B2 (en) | Antibiotic C-15003 | |
| Vondrová et al. | 16α-hydroxylation of progesterone by a strain of Actinomyces globosus | |
| GB2042502A (en) | Antibiotics c-14482 b1,b2 and b3 | |
| KR810001056B1 (en) | Process for preparing antibiotic c-15003 | |
| KR820001342B1 (en) | Process for rpeparing demethyl maytansinoids compounds | |
| JPS6213959B2 (en) |